WallStSmart
PMN

ProMIS Neurosciences Inc.

NASDAQ: PMN · HEALTHCARE · BIOTECHNOLOGY

$11.15
+2.76% today

Updated 2026-04-29

Market cap
$99.99M
P/E ratio
P/S ratio
4,016.22x
EPS (TTM)
$-22.61
Dividend yield
52W range
$6 – $40
Volume
0.0M

ProMIS Neurosciences Inc. (PMN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-45.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-9.1%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-13.2%
2026-03-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-06$0.00+100.0%$12.51$10.88-13.0%
2026-03-25$-30.05-348.1%$17.43$15.13-13.2%
2025-11-12$-0.24+0.0%$0.40$0.39-1.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.21$0.00+100.0%
2025-12-31$-6.71$-30.05-348.1%
2025-09-30$-0.24$-0.24+0.0%
2025-06-30$-0.16$-0.29-81.2%
2025-03-31$-0.17$-0.01+95.8%
2024-12-31$-0.16$0.12+175.0%
2024-09-30$-0.07$0.43+720.6%
2024-06-30$-0.14$-0.13+7.1%
2024-03-31$-0.20$-0.19+5.0%$6275.00
2023-12-31$-0.27$-0.29-7.4%
2023-09-30$-0.33$-0.19+42.4%

Frequently asked questions

Has ProMIS Neurosciences Inc. beaten earnings estimates?
ProMIS Neurosciences Inc. has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -45.3% over the last 4 quarters.
How does PMN stock react to earnings?
PMN stock has moved an average of -9.1% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.